J
J. Guéris
Researcher at Yale University
Publications - 18
Citations - 1077
J. Guéris is an academic researcher from Yale University. The author has contributed to research in topics: Parathyroid hormone & Hyperparathyroidism. The author has an hindex of 13, co-authored 18 publications receiving 1062 citations.
Papers
More filters
Journal ArticleDOI
Vitamin D metabolites and bone mineralization in man.
TL;DR: It is concluded that 1alpha,25(OH)2D3 is not the sole biologically active metabolite of vitamin D in man and that the subsequent rise in serum phosphate concentrations along with the direct actions of 1 alpha-25-hydroxyvitamin D3, 24,25 (OH) 2D3, and possibly 25(OH-D3 on bone cells all participate in the restoration of normal bone formation and bone mineralization in vitamin D-deficient man.
Journal ArticleDOI
On the pathogenesis of so-called idiopathic hypercalciuria.
TL;DR: Two subtypes of patients identified as having persistent hypercalciuria during a period of low calcium intake were divided into two subtypes on the basis of their response to the administration of methylchlorothiazide and 25-hydroxyvitamin D 3.
Journal ArticleDOI
Comparison of Intact, Midregion, and Carboxy Terminal Assays of Parathyroid Hormone for the Diagnosis of Bone Disease in Hemodialyzed Patients
Martine-Esther Cohen Solal,Jean-Luc Sebert,Bernard Boudailliez,A. Marie,Philippe Moriniere,J. Guéris,Roger Bouillon,Albert Fournier +7 more
TL;DR: It is concluded that the intact PTH measurement is superior to C-terminal and midregion assays for the prediction of the histological type of bone disease in hemodialyzed patients and should be of considerable value to adapt their treatment in order to avoid the emergence of both severe hyperparathyroidism and adynamic bone disease.
Journal Article
Calcium carbonate, an aluminum-free agent for control of hyperphosphatemia, hypocalcemia, and hyperparathyroidism in uremia.
Albert Fournier,Philippe Moriniere,Sebert Jl,Dkhissi H,Atik A,Leflon P,Renaud H,J. Guéris,I. Grégoire,Idrissi A +9 more
Journal ArticleDOI
Comparison of 1α-hydroxycholecalciferol and 25-hydroxycholecalciferol in the treatment of renal osteodystrophy: Greater effect of 25-hydroxycholecalciferol on bone mineralization
Albert Fournier,Philippe Bordier,J. Guéris,Sebert Jl,Pierre J. Marie,Christine Ferrière,Jeanine Bedrossian,Hector F. DeLuca +7 more
TL;DR: Large dosages of 25-OH-D 3 are concluded to induce more effectively bone mineralization in spite of a smaller increase of the P Ca × P PO 4 product and may be therefore a better treatment for a renal osteomalacia.